chartexchange

Abbott initiates VOYAGER clinical trial for investigational Encantor™ software-guided balloon-expandable TAVI system to treat aortic stenosis

PR Newswire | Nov 19, 2026 9:00 AM EST

Abbott's Encantor system includes software-guided deployment technology designed to help optimize valve expansion to the patient's unique anatomy, supporting precise implantation and consistent valve performance Encantor early feasibility study data will be presented at PCR London Valves...

Read original article